KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PHG - US5004723038
26.62 USD
-0.39 (-1.44%)
26.62 USD
0 (0%)
Overall PHG gets a fundamental rating of 4 out of 10. We evaluated PHG against 187 industry peers in the Health Care Equipment & Supplies industry. PHG has a medium profitability rating, but doesn't score so well on its financial health evaluation. PHG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHG was profitable.
In the past year PHG had a positive cash flow from operations.
In multiple years PHG reported negative net income over the last 5 years.
Of the past 5 years PHG 4 years had a positive operating cash flow.
1.2 Ratios
PHG has a better Return On Assets (0.61%) than 73.80% of its industry peers.
PHG has a better Return On Equity (1.56%) than 74.87% of its industry peers.
PHG has a Return On Invested Capital of 4.49%. This is in the better half of the industry: PHG outperforms 75.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.49% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHG's Profit Margin of 0.91% is fine compared to the rest of the industry. PHG outperforms 73.80% of its industry peers.
PHG's Operating Margin of 6.11% is fine compared to the rest of the industry. PHG outperforms 71.66% of its industry peers.
In the last couple of years the Operating Margin of PHG has declined.
Looking at the Gross Margin, with a value of 43.85%, PHG is doing worse than 63.64% of the companies in the same industry.
PHG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
PHG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PHG has less shares outstanding
Compared to 5 years ago, PHG has more shares outstanding
Compared to 1 year ago, PHG has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.89 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.89, PHG perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
PHG has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as PHG would need 19.41 years to pay back of all of its debts.
PHG has a better Debt to FCF ratio (19.41) than 71.66% of its industry peers.
PHG has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHG is somewhat dependend on debt financing.
The Debt to Equity ratio of PHG (0.69) is worse than 66.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.89 |
ROIC/WACC0.69
WACC6.55%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHG should not have too much problems paying its short term obligations.
The Current ratio of PHG (1.26) is worse than 81.82% of its industry peers.
PHG has a Quick Ratio of 1.26. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
PHG has a worse Quick ratio (0.81) than 82.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.15% over the past year.
PHG shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
The Revenue has decreased by -0.81% in the past year.
PHG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
The Earnings Per Share is expected to grow by 13.05% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.41% on average over the next years.
EPS Next Y3.9%
EPS Next 2Y5.55%
EPS Next 3Y8.25%
EPS Next 5Y13.05%
Revenue Next Year-1.88%
Revenue Next 2Y0.58%
Revenue Next 3Y1.85%
Revenue Next 5Y3.41%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.39 indicates a correct valuation of PHG.
87.17% of the companies in the same industry are more expensive than PHG, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.54, PHG is valued a bit cheaper.
The Price/Forward Earnings ratio is 14.73, which indicates a correct valuation of PHG.
87.70% of the companies in the same industry are more expensive than PHG, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, PHG is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.39 | ||
| Fwd PE | 14.73 |
4.2 Price Multiples
PHG's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PHG is cheaper than 87.17% of the companies in the same industry.
73.80% of the companies in the same industry are more expensive than PHG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.42 | ||
| EV/EBITDA | 12.07 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.94
PEG (5Y)N/A
EPS Next 2Y5.55%
EPS Next 3Y8.25%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.26%, PHG is a good candidate for dividend investing.
PHG's Dividend Yield is rather good when compared to the industry average which is at 1.34. PHG pays more dividend than 98.93% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, PHG pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.26% |
5.2 History
The dividend of PHG decreases each year by -70.49%.
PHG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
0.62% of the earnings are spent on dividend by PHG. This is a low number and sustainable payout ratio.
DP0.62%
EPS Next 2Y5.55%
EPS Next 3Y8.25%
26.62
-0.39 (-1.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners44.69%
Inst Owner Change-2.3%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap25.63B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target32.44 (21.86%)
Short Float %0.22%
Short Ratio2.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.26% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)1.32%
PT rev (3m)1.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.38%
EPS NY rev (1m)3.66%
EPS NY rev (3m)2.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.39 | ||
| Fwd PE | 14.73 | ||
| P/S | 1.23 | ||
| P/FCF | 50.42 | ||
| P/OCF | 19.91 | ||
| P/B | 2.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.07 |
EPS(TTM)1.73
EY6.5%
EPS(NY)1.81
Fwd EY6.79%
FCF(TTM)0.53
FCFY1.98%
OCF(TTM)1.34
OCFY5.02%
SpS21.72
BVpS12.63
TBVpS-2.06
PEG (NY)3.94
PEG (5Y)N/A
Graham Number22.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.49% | ||
| ROICexc | 4.97% | ||
| ROICexgc | 16.33% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.89 |
F-Score8
WACC6.55%
ROIC/WACC0.69
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y3.9%
EPS Next 2Y5.55%
EPS Next 3Y8.25%
EPS Next 5Y13.05%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-1.88%
Revenue Next 2Y0.58%
Revenue Next 3Y1.85%
Revenue Next 5Y3.41%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.79%
EBIT Next 3Y20.32%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NVR- NY / PHG FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
ChartMill assigns a fundamental rating of 4 / 10 to PHG.
What is the valuation status for PHG stock?
ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NVR- NY?
KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.
What are the PE and PB ratios of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
The Price/Earnings (PE) ratio for KONINKLIJKE PHILIPS NVR- NY (PHG) is 15.39 and the Price/Book (PB) ratio is 2.11.
What is the expected EPS growth for KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NVR- NY (PHG) is expected to grow by 3.9% in the next year.